Indication: Pancreatic Adenocarcinoma
Registry To Evaluate Effectiveness And Safety Of The NanoKnife System For The Ablation Of Stage 3 Pancreatic Adenocarcinoma: The Direct Registry For IRE Cancer Treatment
Sub-indication: Pancreatic Adenocarcinoma
Study Type: Registry
Principal Investigator: Robert Martin, M.D., Ph.D.University of Louisville Physicians - Surgical Oncology
Sponsor: Sponsor: AngioDynamics, Inc.
Learn more at ClinicalTrials.gov
Email for more information: mary.healey@louisville.edu